Resistance to Trastuzumab: A Necessary Evil or a Temporary Challenge?

This publication has 114 references indexed in Scilit:

• Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth
  Annals of Oncology, 2002
• EGF receptors as transcription factors: ridiculous or sublime?
  Nature Cell Biology, 2001
• Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
  JNCI Journal of the National Cancer Institute, 2000
• The Hallmarks of Cancer
  Cell, 2000
• A novel splice variant ofHER2 with increased transformation activity
  Molecular Carcinogenesis, 1998
• Circulating concentrations of insulin-like growth factor I and risk of breast cancer
  The Lancet, 1998
• Heregulin β1 induces the down regulation and the ubiquitin‐proteasome degradation pathway of p185^HER2 oncoprotein
  FEBS Letters, 1998
• Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor Combinations
  Published by Elsevier ,1996
• Nuclear Localization of P185neu Tyrosine Kinase and Its Association with Transcriptional Transactivation
  Biochemical and Biophysical Research Communications, 1994
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985